Sign Out
Data on the use of Hyoscine Butylbromide in pregnant women are limited. Animal studies have shown no direct or indirect adverse effects to reproductive toxicity. Information on the excretion of Hyoscine Butylbromide and its metabolites in human milk is limited.
As a precautionary measure, it is preferable to avoid the use of Hyoscine Butylbromide during pregnancy and lactation.
No studies have been conducted on the effects of human fertility.
